Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers

Immunotherapy may slow the growth of malignant pleural mesothelioma

Immunotherapy for mesothelioma could be on the horizon

CAR T-cell therapy can be used to send multiple myeloma into lasting remission

Findings of a phase I/II study of nivolumab in patients with virus-associated tumours

New personalised therapies for lung cancer

Nivolumab and ipilimumab for metastatic sarcoma

9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy

Pooled analysis of avelumab for metastatic urothelial carcinoma

EADO conference highlights

Intralesional T-VEC and combinations for melanoma

Molecular testing for targeted therapies